Company ValuationThe company's valuation levels are considered a bit rich at this point.
Earnings GuidanceRepligen expects full-year 2025 GAAP net earnings of $0.76 - $0.85 per diluted share, down from the original guidance range of $0.90 - $0.99 per diluted share.
Economic ConditionsUncertainty regarding current market and economic conditions, including tariff and Forex issues, is leading to a Hold rating on RGEN shares.